Your browser doesn't support javascript.
loading
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.
Abu-Khalaf, Maysa M; Alex Hodge, K; Hatzis, Christos; Baldelli, Elisa; El Gazzah, Emna; Valdes, Frances; Sikov, William M; Mita, Monica M; Denduluri, Neelima; Murphy, Rita; Zelterman, Daniel; Liotta, Lance; Dunetz, Bryant; Dunetz, Rick; Petricoin, Emanuel F; Pierobon, Mariaelena.
Afiliação
  • Abu-Khalaf MM; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.
  • Alex Hodge K; School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA.
  • Hatzis C; HiFiBiO Therapeutics, Cambridge, MA, USA.
  • Baldelli E; School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA.
  • El Gazzah E; School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA.
  • Valdes F; Sylvester Comprehensive Cancer Center (UM SCCC), University of Miami, Miami, FL, USA.
  • Sikov WM; Women and Infants Hospital of Rhode Island, Providence, RI, USA.
  • Mita MM; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Denduluri N; Virginia Cancer Specialists, Fairfax, VA, USA.
  • Murphy R; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.
  • Zelterman D; Yale University, New Haven, CT, USA.
  • Liotta L; School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA.
  • Dunetz B; Side Out Foundation, Fairfax, VA, USA.
  • Dunetz R; Side Out Foundation, Fairfax, VA, USA.
  • Petricoin EF; School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA.
  • Pierobon M; School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA. mpierobo@gmu.edu.
NPJ Precis Oncol ; 7(1): 18, 2023 Feb 16.
Article em En | MEDLINE | ID: mdl-36797347
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos